Severe hyponatraemia associated with desmopressin nasal spray to treat clozapine-induced nocturnal enuresis.
Sarma
Shanthi
S
Ward
Warren
W
O'Brien
Justin
J
Frost
Aaron D J
AD
D050034:Antidiuretic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004775:Enuresis / Q000139:chemically induced* / Q000188:drug therapy*; D015600:Glasgow Coma Scale; D006801:Humans; D007010:Hyponatremia / Q000097:blood / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy; D012720:Severity of Illness Index; D012964:Sodium / Q000008:administration & dosage / Q000097:blood
D050034:Antidiuretic Agents; D014150:Antipsychotic Agents; D012964:Sodium; D003894:Deamino Arginine Vasopressin; D003024:Clozapine